Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 08 2019
Historique:
received: 18 10 2018
accepted: 01 08 2019
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 20 11 2020
Statut: epublish

Résumé

Human milk oligosaccharide (HMO) composition varies among lactating mothers and changes during the course of lactation period. Interindividual variation is largely driven by fucosyltransferase (FUT2 and FUT3) polymorphisms resulting in 4 distinct milk groups. Little is known regarding whether maternal physiological status contributes to HMO variability. We characterized the trajectories of 20 major HMOs and explored whether maternal pre-pregnancy body mass index (ppBMI), mode of delivery, or parity may affect milk HMO composition. Using longitudinal breastmilk samples from healthy mothers (n = 290) across 7 European countries, we characterized HMO composion and employed mixed linear models to explore associations of maternal characteristics with individual HMOs. We observed HMO-specific temporal trajectories and milk group dependencies. We observed relatively small but significant differences in HMO concentrations based on maternal ppBMI, mode of delivery and parity. Our findings suggest that HMO composition to be regulated time-dependently by an enzyme as well as substrate availability and that ppBMI, mode of delivery, and parity may influence maternal physiology to affect glycosylation marginally within the initital period of lactation. Our observational study is the largest European standardized and longitudinal (up to 4 months) milk collection study assessing HMO concentrations and basic maternal characteristics. Time of lactation and milk groups had the biggest impact on HMO variation. Future studies need to elucidate these observations and assess the physiological significance for the breastfed infant.

Identifiants

pubmed: 31409852
doi: 10.1038/s41598-019-48337-4
pii: 10.1038/s41598-019-48337-4
pmc: PMC6692355
doi:

Substances chimiques

Oligosaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11767

Références

Pediatrics. 2011 Feb;127(2):e359-66
pubmed: 21262884
Indian J Endocrinol Metab. 2013 Jan;17(1):50-9
pubmed: 23776853
Ann Hematol. 2002 Oct;81(10):558-65
pubmed: 12424536
Int J Food Microbiol. 2011 Sep 1;149(1):58-64
pubmed: 21342711
Early Hum Dev. 2015 Nov;91(11):629-35
pubmed: 26375355
Br J Nutr. 2010 Nov;104(9):1261-71
pubmed: 20522272
J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & Ne:S131-S132
pubmed: 27741156
Pediatrics. 2004 May;113(5):e465-71
pubmed: 15121990
Carbohydr Res. 2016 Sep 2;432:62-70
pubmed: 27448325
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(7):731-47
pubmed: 20689231
J Pediatr Gastroenterol Nutr. 2017 May;64(5):789-798
pubmed: 27602704
J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):624-631
pubmed: 28107288
Nat Commun. 2016 Jun 24;7:11939
pubmed: 27340092
Annu Rev Nutr. 2000;20:699-722
pubmed: 10940350
Acta Paediatr Suppl. 1999 Aug;88(430):89-94
pubmed: 10569230
Glycoconj J. 1997 Nov;14(7):795-9
pubmed: 9511984
Am J Clin Nutr. 2017 May;105(5):1086-1100
pubmed: 28356278
Pediatrics. 2011 Dec;128(6):e1520-31
pubmed: 22123889
Glycobiology. 2014 Aug;24(8):728-39
pubmed: 24789815
Nutrients. 2016 Jun 08;8(6):
pubmed: 27338459
Glycobiology. 2001 May;11(5):365-72
pubmed: 11425797
Front Pediatr. 2018 Jul 02;6:190
pubmed: 30013961
Br J Nutr. 2003 Jan;89(1):61-9
pubmed: 12568665
J Nutr. 2018 Nov 1;148(11):1733-1742
pubmed: 30247646
BJOG. 2006 Apr;113(4):441-5
pubmed: 16489937
Anal Chim Acta. 2018 Jun 20;1010:86-96
pubmed: 29447675
Pediatr Clin North Am. 2013 Feb;60(1):49-74
pubmed: 23178060
Prog Food Nutr Sci. 1990;14(1):1-43
pubmed: 2092340
Mol Biol Evol. 2009 Sep;26(9):1993-2003
pubmed: 19487333
J Pediatr Gastroenterol Nutr. 1989 May;8(4):486-90
pubmed: 2723940
PLoS One. 2017 Feb 9;12(2):e0171814
pubmed: 28182762
Adv Exp Med Biol. 2001;501:299-306
pubmed: 11787693
Proc Natl Acad Sci U S A. 1984 Jul;81(13):4193-7
pubmed: 6588382

Auteurs

Tinu Mary Samuel (TM)

Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.

Aristea Binia (A)

Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.

Carlos Antonio de Castro (CA)

Nestlé Research, Société des Produits Nestlé S.A., Singapore, Singapore.

Sagar K Thakkar (SK)

Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.

Claude Billeaud (C)

Hôpital des enfants, CHU Pellegrin, Bordeaux, France.

Massimo Agosti (M)

Ospedale del Ponte, Varese, Italy.

Isam Al-Jashi (I)

Al Jashi Isam Private Med. Practice, Bucharest, Romania.

Maria Jose Costeira (MJ)

Instituto de Investigação em Ciências da Vida e Saúde, Braga, Portugal.

Giovanna Marchini (G)

Karolinska University Hospital, Stockholm, Sweden.

Cecilia Martínez-Costa (C)

Hospital Clínico Universitario, University of Valencia, Valencia, Spain.

Jean-Charles Picaud (JC)

Hôpital de la Croix Rousse, Lyon, France.

Tom Stiris (T)

Oslo University Hospital, Oslo, Norway.

Silvia-Maria Stoicescu (SM)

Polizu Hospital, Bucharest, Romania.

Mireille Vanpeé (M)

Karolinska University Hospital, Stockholm, Sweden.

Magnus Domellöf (M)

Umeå University, Umeå, Sweden.

Sean Austin (S)

Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.

Norbert Sprenger (N)

Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland. Norbert.Sprenger@rdls.nestle.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH